NDC 63402-681-01 - UTIBRON NEOHALER
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63402-681
- Requested NDC
- 63402-681-01
- Package NDCs from labels
- 63402-681-01, 63402-681-60, 63402-681-06, 63402-681-02, 63402-681-12
- Manufacturer
- Sunovion Pharmaceuticals Inc.
- Effective date
- 2019-05-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| UTIBRON NEOHALER - Sunovion Pharmaceuticals Inc. | Sunovion Pharmaceuticals Inc. | 2019-05-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63402-681-01 | EA - Each | 63402-681 | fdf9a6c3-5389-43b6-b079-50d744dc12f6 | 1 | 2018-04-19 |
| 63402-681-06 | EA - Each | 63402-681 | 9eef7d49-3376-4482-b546-cd4a99897904 | 1 | 2018-04-19 |
| 63402-681-60 | EA - Each | 63402-681 | c91b1e50-982d-4197-8a4c-105b40d16fab | 1 | 2018-06-11 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glycopyrrolate | GLYCOPYRROLATE | REMEDYREPACK INC. | a338ef22-c243-4075-b02d-bcd5b590104a | 2026-03-26 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | REMEDYREPACK INC. | fafea739-87d0-4421-833f-eb066791504c | 2026-03-26 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Lifestar Pharma LLC | 0f4a4b94-71e0-49ed-8f1e-c760e4dd3137 | 2026-03-25 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Major Pharmaceuticals | 6e5bfe6d-d321-4f0f-86e2-457d8fd10a6a | 2026-03-19 | Warnings, Adverse reactions | V92SO9WP2I |
| glycopyrrolate | GLYCOPYRROLATE | Bionpharma Inc. | 512d3f1e-c35c-87c2-e063-6394a90a8de0 | 2026-03-05 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | NCS HealthCare of KY, LLC dba Vangard Labs | 5ed930b7-a36e-4bf8-b1d1-dad238d3dd18 | 2026-02-25 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Bryant Ranch Prepack | 10ea264f-e157-4e13-9d79-b4228daf359d | 2026-02-17 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Florida Pharmaceutical Products, LLC | 2cda1ed5-10bb-4651-acbf-be44ad709665 | 2026-02-12 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycate | GLYCOPYRROLATE | Intra-Sana Laboratories | 830ba1be-bef3-417c-a915-964cc6005b92 | 2026-01-13 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Bryant Ranch Prepack | eaf38b98-006f-4f4e-bc1c-6fe381f44b36 | 2026-01-07 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Bryant Ranch Prepack | b96c54a1-b8a5-4132-ae6d-725e0e5b91f4 | 2026-01-07 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate Oral Solution | GLYCOPYRROLATE | AJENAT PHARMACEUTICALS LLC | 7049feaf-004a-481f-b129-996b21c3170a | 2025-12-29 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Jvet Pharmaceuticals LLC | 4b335c67-4f8f-47e5-abfc-f8c2c15496d7 | 2025-12-19 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Aurolife Pharma LLC | 677f8495-a870-45b6-bb65-75b449f040ce | 2025-12-11 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Chartwell RX, LLC | 5773cf63-4006-4d8f-b53b-c84bcfe19e4a | 2025-12-10 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Rising Pharma Holdings, Inc. | 58c4cb1f-59b8-4be9-a222-2264ca077d93 | 2025-12-03 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Solco Healthcare US, LLC | 2972f22e-378c-450b-8869-1354a9bd0ffc | 2025-11-30 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Solco Healthcare US, LLC | 3707f06a-6cba-4f5c-86ab-fb95bc2a933c | 2025-11-30 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | ProPharma Distribution | 430635e8-7c9e-77f6-e063-6294a90a4c8a | 2025-11-07 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Henry Schein, Inc. | 83602e34-7a8c-4606-b43e-23ab909b6c1a | 2025-11-05 | Warnings, Adverse reactions | V92SO9WP2I |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.